Thyreos
Lincoln
About Thyreos
Thyreos is a company that creates herpesvirus vaccines and vaccine vectors for the animal and human health markets. The vaccines are built on a recombinant herpesvirus platform, which elicits strong immune responses without infecting the nervous system. Periodic reactivation of the latent infection causes the contagious shedding of infectious viruses, which is frequently associated with mild or severe disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.8M
- Funding stage: Seed
- Last round: Seed (Dec 2022)
- Website: thyreosvaccines.com
Industries & Categories
Health Care
Social Profiles
Canonical: https://fsome.com/organization/thyreos-78736 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.